Human Error Root Cause Analysis & CAPA in GMP Operations
Linking human error analysis to SOP redesign and system fixes
Linking Human Error Analysis to SOP Redesign and System Fixes Linking Human Error Analysis to SOP Redesign and System Fixes Context In pharmaceutical and biotechnology settings, ensuring compliance with Good Manufacturing Practices (GMP) is essential for maintaining product quality and patient safety. Human errors, which can lead to deviations from established protocols, represent a significant risk within these highly regulated environments. Regulatory authorities expect organizations to conduct thorough human error root cause analysis (RCA) as part of Corrective and Preventive Action (CAPA) initiatives. This article aims to provide a comprehensive overview of the importance of linking human error analysis to…
Using just culture principles in GMP human error management
Using Just Culture Principles in GMP Human Error Management Using Just Culture Principles in GMP Human Error Management In the realm of pharmaceutical manufacturing and medical device production, ensuring compliance with Good Manufacturing Practices (GMP) is paramount. A significant challenge faced by organizations within these sectors is managing human error effectively. The application of human error root cause analysis plays a critical role in this context, particularly when addressing deviations and implementing corrective and preventive actions (CAPA). This regulatory explainer manual aims to elucidate the concept of just culture principles in the realm of GMP human error management, focusing on…
Common FDA findings on weak human error investigations and CAPA
Common FDA findings on weak human error investigations and CAPA Common FDA findings on weak human error investigations and CAPA This article serves as a comprehensive guide for regulatory affairs professionals, quality assurance (QA) experts, and validation specialists within the pharmaceutical and biotechnology sectors. It outlines the expectations and guidelines surrounding human error root cause analysis, corrective and preventive actions (CAPA), and the regulatory context established by agencies including the FDA, EMA, and MHRA. Context of Human Factors in GMP Operations Human error is a contributing factor in many deviations observed in Good Manufacturing Practice (GMP) operations. The identification and…
Digital tools to support human error classification and trending
Digital tools to support human error classification and trending Digital tools to support human error classification and trending The importance of human factors in the fields of pharmaceutical and medical device manufacturing cannot be overstated. Ensuring compliance with Good Manufacturing Practices (GMP) requires thorough understanding and control over human errors, particularly in the context of validations and quality assurance. This regulatory explainer manual outlines how digital tools can effectively support human error root cause analysis and related activities in the industry. Context In the regulatory landscape, organizations must be vigilant in monitoring and managing human error to maintain compliance and…
Reducing repeat human error deviations through targeted interventions
Reducing repeat human error deviations through targeted interventions Reducing repeat human error deviations through targeted interventions Context of Human Factors in Regulatory Affairs In the pharmaceutical and biotechnology sectors, ensuring product quality and compliance with regulatory standards is paramount. Human factors play a crucial role in this ecosystem, particularly in Good Manufacturing Practice (GMP) operations. When deviations occur due to human errors, they can lead to regulatory scrutiny, product recalls, or, at worst, patient harm. This article provides a comprehensive guide on performing human error root cause analysis and implementing Corrective and Preventive Actions (CAPA) to mitigate such errors effectively,…